Comparative Pharmacology
Head-to-head clinical analysis: CONSTULOSE versus GLYCOLAX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CONSTULOSE versus GLYCOLAX.
CONSTULOSE vs GLYCOLAX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a synthetic disaccharide that is not absorbed in the small intestine. In the colon, it is metabolized by bacteria to short-chain fatty acids, leading to an osmotic effect that draws water into the bowel, thereby softening stools and increasing bowel motility. In hepatic encephalopathy, lactulose acidifies the colonic environment, promoting the conversion of ammonia (NH3) to ammonium (NH4+), which is trapped and excreted in feces.
Osmotic laxative. Polyethylene glycol (PEG) increases intraluminal water volume in the colon by osmosis, promoting stool passage and relieving constipation.
10-20 g (15-30 mL) orally once daily, increased to 30-45 g (45-60 mL) if needed; or 30-45 g (45-60 mL) orally every 6-8 hours for hepatic encephalopathy.
17 g (1 heaping tablespoon) dissolved in 4-8 ounces of liquid once daily, orally.
None Documented
None Documented
Not applicable due to minimal systemic absorption; local action in colon. In cases of systemic absorption, half-life is not clinically relevant.
Not applicable due to negligible systemic absorption; local colonic transit time approximately 2-4 hours.
Primarily fecal (unchanged); minimal systemic absorption (<3%), thus negligible renal excretion.
Minimally absorbed; excreted primarily unchanged in feces via osmotic action. Renal excretion negligible (<0.2% absorbed dose).
Category C
Category C
Osmotic Laxative
Osmotic Laxative